AU Stock MarketDetailed Quotes
PXS Pharmaxis Ltd
- 0.027
- 0.0000.00%
20min DelayTrading Apr 12 10:00 AET
19.51MMarket Cap-1588P/E (Static)
0.000High0.000Low0Volume0.000Open0.027Pre Close0.00Turnover0.03052wk High0.00%Turnover Ratio722.61MShares0.02652wk Low-0.017EPS TTM8.93MFloat Cap0.150Historical HighLossP/E (Static)330.70MShs Float0.026Historical Low-0.017EPS LYR0.00%Amplitude--Dividend TTM2.08P/B1Lot Size--Div YieldTTM
Pharmaxis Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | (FY)Jun 30, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -22.37%5.77M | 11.17%7.43M | -4.94%6.68M | 23.80%7.03M | -22.05%5.68M | -45.19%7.28M | -7.32%13.29M | -75.17%14.34M | 1,046.56%57.74M | 55.58%5.04M |
| Operating revenue | -22.37%5.77M | 11.17%7.43M | -4.94%6.68M | 23.80%7.03M | -22.05%5.68M | -45.19%7.28M | -7.32%13.29M | -75.17%14.34M | 1,046.56%57.74M | 55.58%5.04M |
| Cost of revenue | 2.71M | 62.84%1.86M | ||||||||
| Gross profit | -58.81%3.06M | 11.17%7.43M | -4.94%6.68M | 23.80%7.03M | -22.05%5.68M | -45.19%7.28M | -7.32%13.29M | -75.17%14.34M | 1,716.90%57.74M | 51.62%3.18M |
| Operating expense | -6.12%28.35M | 10.51%30.19M | -4.11%27.32M | -9.71%28.49M | -6.15%31.56M | -7.88%33.63M | -1.12%36.51M | -14.35%36.92M | -26.21%43.1M | 7.80%58.41M |
| Selling and administrative expenses | 6.67%15.83M | -9.19%14.84M | 3.35%16.34M | -4.92%15.81M | 2.12%16.63M | 6.99%16.28M | 1.41%15.22M | -28.47%15.01M | 17.94%20.98M | -10.71%17.79M |
| -Selling and marketing expense | -59.60%305K | -48.60%755K | 9.14%1.47M | 18.49%1.35M | -2.32%1.14M | 9.61%1.16M | -3.63%1.06M | -43.88%1.1M | -79.40%1.96M | -31.46%9.52M |
| -General and administrative expense | 10.23%15.52M | -5.30%14.08M | 2.81%14.87M | -6.64%14.47M | 2.47%15.49M | 6.79%15.12M | 1.80%14.16M | -26.88%13.91M | 130.04%19.02M | 37.11%8.27M |
| Research and development costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -25.82%17.7M |
| Depreciation amortization depletion | -42.93%1.85M | 2.73%3.24M | -2.60%3.15M | 23.56%3.24M | -21.82%2.62M | 9.51%3.35M | 1.02%3.06M | -16.93%3.03M | -74.25%3.65M | 193.63%14.15M |
| -Depreciation and amortization | -42.93%1.85M | 2.73%3.24M | -2.60%3.15M | 23.56%3.24M | -21.82%2.62M | 9.51%3.35M | 1.02%3.06M | -16.93%3.03M | -74.25%3.65M | 193.63%14.15M |
| Provision for doubtful accounts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---54K | ---- |
| Other operating expenses | -11.94%10.67M | 54.76%12.12M | -17.12%7.83M | -23.27%9.45M | -12.03%12.31M | -23.21%14M | -3.47%18.23M | 1.89%18.88M | 111.40%18.53M | 57.07%8.77M |
| Operating profit | -11.07%-25.29M | -10.30%-22.77M | 3.84%-20.64M | 17.06%-21.47M | 1.76%-25.88M | -13.47%-26.35M | -2.82%-23.22M | -254.29%-22.58M | 126.50%14.64M | -6.03%-55.23M |
| Net non-operating interest income (expenses) | -100.78%-106K | 4,367.08%13.61M | -112.64%-319K | 276.15%2.52M | 1,817.14%671K | -56.25%35K | -97.82%80K | 7.46%3.67M | 161.38%3.42M | -2,126.80%-5.57M |
| Non-operating interest income | -25.00%117K | 212.00%156K | -98.02%50K | 177.67%2.52M | 52.01%909K | -14.94%598K | -42.04%703K | 68.24%1.21M | -58.44%721K | -35.62%1.74M |
| Non-operating interest expense | 101.66%223K | -3,746.61%-13.46M | --369K | ---- | -57.73%238K | -9.63%563K | 125.34%623K | 8.79%-2.46M | -136.92%-2.7M | 147.95%7.3M |
| Other net income (expenses) | 94.38%14.03M | -59.87%7.22M | 259.82%17.99M | -3.01%5M | -84.17%5.16M | 579.55%32.57M | 95.23%4.79M | 440.75%2.46M | 108.96%454K | -227.18%-5.07M |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 47.43%-174K | 96.23%-331K | -419.70%-8.78M |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 419.70%8.78M |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -47.43%174K | --331K | ---- |
| Other non-operating income (expenses) | 94.38%14.03M | -59.87%7.22M | 259.82%17.99M | -3.01%5M | -84.17%5.16M | 579.55%32.57M | 82.31%4.79M | 234.90%2.63M | -78.87%785K | -34.54%3.72M |
| Income before tax | -486.78%-11.36M | 34.81%-1.94M | 78.70%-2.97M | 30.49%-13.94M | -412.43%-20.06M | 134.99%6.42M | -11.49%-18.35M | -188.91%-16.46M | 135.79%18.51M | -18.79%-51.72M |
| Income tax | 0 | 0 | 0 | 0 | 0 | -8K | 0 | -83.33%7K | -59.22%42K | 5,050.00%103K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -486.78%-11.36M | 34.81%-1.94M | 78.70%-2.97M | 30.49%-13.94M | -412.04%-20.06M | 135.04%6.43M | -11.44%-18.35M | -189.15%-16.46M | 135.64%18.47M | -19.02%-51.82M |
| Net income continuous operations | -486.78%-11.36M | 34.81%-1.94M | 78.70%-2.97M | 30.49%-13.94M | -412.04%-20.06M | 135.04%6.43M | -11.44%-18.35M | -189.15%-16.46M | 135.64%18.47M | -19.02%-51.82M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -486.78%-11.36M | 34.81%-1.94M | 78.70%-2.97M | 30.49%-13.94M | -412.04%-20.06M | 135.04%6.43M | -11.44%-18.35M | -189.15%-16.46M | 135.64%18.47M | -19.02%-51.82M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -486.78%-11.36M | 34.81%-1.94M | 78.70%-2.97M | 30.49%-13.94M | -412.04%-20.06M | 135.04%6.43M | -11.44%-18.35M | -189.15%-16.46M | 135.64%18.47M | -19.02%-51.82M |
| Diluted earnings per share | -408.82%-0.0173 | 51.43%-0.0034 | 80.00%-0.007 | 33.46%-0.035 | -363.00%-0.0526 | 134.48%0.02 | -11.54%-0.058 | -188.14%-0.052 | 135.12%0.059 | -19.15%-0.168 |
| Basic earnings per share | -408.82%-0.0173 | 51.43%-0.0034 | 80.00%-0.007 | 33.46%-0.035 | -363.00%-0.0526 | 134.48%0.02 | -11.54%-0.058 | -188.14%-0.052 | 135.12%0.059 | -19.15%-0.168 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data